JP2017505825A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017505825A5 JP2017505825A5 JP2016569580A JP2016569580A JP2017505825A5 JP 2017505825 A5 JP2017505825 A5 JP 2017505825A5 JP 2016569580 A JP2016569580 A JP 2016569580A JP 2016569580 A JP2016569580 A JP 2016569580A JP 2017505825 A5 JP2017505825 A5 JP 2017505825A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- application publication
- patent application
- gnpd
- mintel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461941200P | 2014-02-18 | 2014-02-18 | |
| US61/941,200 | 2014-02-18 | ||
| PCT/US2015/016267 WO2015126874A1 (en) | 2014-02-18 | 2015-02-18 | Topical anhydrous fill formulation for ultraviolet filters |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017505825A JP2017505825A (ja) | 2017-02-23 |
| JP2017505825A5 true JP2017505825A5 (enExample) | 2018-03-15 |
| JP6765308B2 JP6765308B2 (ja) | 2020-10-07 |
Family
ID=53878887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016569580A Active JP6765308B2 (ja) | 2014-02-18 | 2015-02-18 | 紫外フィルターのための外用無水充填製剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20170172895A1 (enExample) |
| EP (1) | EP3107526B1 (enExample) |
| JP (1) | JP6765308B2 (enExample) |
| KR (1) | KR102328636B1 (enExample) |
| AU (1) | AU2015219210B2 (enExample) |
| BR (1) | BR112016018768B1 (enExample) |
| DK (1) | DK3107526T3 (enExample) |
| ES (1) | ES2818090T3 (enExample) |
| HR (1) | HRP20201431T1 (enExample) |
| HU (1) | HUE050440T2 (enExample) |
| PL (1) | PL3107526T3 (enExample) |
| PT (1) | PT3107526T (enExample) |
| SI (1) | SI3107526T1 (enExample) |
| WO (1) | WO2015126874A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3352725A4 (en) * | 2015-09-24 | 2019-05-01 | Deckner Consulting Services, LLC | HIGHLY EFFICIENT SOLAR PROTECTION COMPOSITION |
| US10485745B2 (en) * | 2016-04-29 | 2019-11-26 | L'oreal | UV-A/UV-B sunscreen composition |
| EP3378463A1 (fr) | 2017-03-20 | 2018-09-26 | Total Marketing Services | Utilisation non-therapeutique d'une huile hydrocarbonee biodegradable |
| US12011494B2 (en) * | 2019-02-28 | 2024-06-18 | L'oreal | Skin perfecting cosmetic compositions and methods of use |
| FR3104957B1 (fr) * | 2019-12-20 | 2022-08-05 | Oreal | Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate |
| US11805889B1 (en) * | 2022-09-20 | 2023-11-07 | David Edward Martin | Wearable sunblock container |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5082661A (en) * | 1990-09-26 | 1992-01-21 | Elizabeth Arden Co., Division Of Conopco, Inc. | Odorless cosmetic compositions in gelatin capsules |
| US5270054A (en) * | 1992-09-03 | 1993-12-14 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic capsules |
| US6124348A (en) * | 1997-07-01 | 2000-09-26 | Lawrence M. Wells | Vitamin C skin formulations |
| US6248339B1 (en) * | 1999-08-13 | 2001-06-19 | Intimate Beauty Corporation | Fragrant body lotion and cream |
| US6475500B2 (en) * | 2000-07-10 | 2002-11-05 | The Procter & Gamble Company | Anhydrous cosmetic compositions |
| JP2003063927A (ja) | 2001-08-29 | 2003-03-05 | Noevir Co Ltd | 非水系化粧料 |
| US20040005279A1 (en) * | 2002-01-24 | 2004-01-08 | L'oreal | Composition containing a semi-crystalline polymer and methods of use |
| US20040228821A1 (en) * | 2003-05-16 | 2004-11-18 | The Procter & Gamble Company | Personal care products comprising active agents in a gel network |
| DE10342860A1 (de) * | 2003-09-15 | 2005-04-21 | Basf Ag | Pulverförmiger Zubereitungen, enthaltend Diethylaminohydroxybenzoyl-hexyl-benzoat |
| JP2010501600A (ja) * | 2006-08-28 | 2010-01-21 | スース，ハンス，アール． | 無水の、尿素を含有する皮膚用または化粧用調製品 |
| ATE529090T1 (de) * | 2007-06-29 | 2011-11-15 | Dow Corning | Silikon-organische gele mit polyalkyloxylenvernetzten silikonelastomeren |
| US9095543B2 (en) * | 2009-05-04 | 2015-08-04 | Elc Management Llc | Cosmetic compositions comprising cyanodiphenylacrylates |
| FR2953715B1 (fr) * | 2009-12-11 | 2012-02-17 | Oreal | Composition filtrante fluide anhydre comprenant une phase huileuse, un filtre triazine particulier et un agent rheologique epaississant ou gelifiant d'huile |
| JP4834775B2 (ja) * | 2010-03-04 | 2011-12-14 | 株式会社 資生堂 | 日焼け止め用組成物 |
| JP5723359B2 (ja) * | 2010-03-24 | 2015-05-27 | 株式会社 資生堂 | 日焼け止め化粧料 |
| BR112013000508A8 (pt) * | 2010-07-08 | 2017-12-05 | Johnson & Johnson Consumer Companies Inc | Composição de emulsão para tratamento de pele |
| FR2974367B1 (fr) * | 2011-04-22 | 2013-05-24 | Oreal | Compositions comprenant un polymere a motif dendrimere carbosiloxane et une quantite elevee de mono-alcool |
| FR2976178B1 (fr) * | 2011-06-09 | 2013-09-27 | Oreal | Creme anhydre solaire comprenant un organopolysiloxane elastomere non emulsionnant, un agent matifiant, un epaississant organique non silicone d'huile |
| JP5893896B2 (ja) * | 2011-11-10 | 2016-03-23 | 株式会社コーセー | 凹凸補正化粧料 |
| EP2819643B1 (en) * | 2012-03-01 | 2017-10-18 | The Procter and Gamble Company | Sunscreen composition comprising uv composite |
-
2015
- 2015-02-18 US US15/115,390 patent/US20170172895A1/en not_active Abandoned
- 2015-02-18 ES ES15752673T patent/ES2818090T3/es active Active
- 2015-02-18 HU HUE15752673A patent/HUE050440T2/hu unknown
- 2015-02-18 JP JP2016569580A patent/JP6765308B2/ja active Active
- 2015-02-18 EP EP15752673.2A patent/EP3107526B1/en active Active
- 2015-02-18 HR HRP20201431TT patent/HRP20201431T1/hr unknown
- 2015-02-18 BR BR112016018768-7A patent/BR112016018768B1/pt active IP Right Grant
- 2015-02-18 DK DK15752673.2T patent/DK3107526T3/da active
- 2015-02-18 PT PT157526732T patent/PT3107526T/pt unknown
- 2015-02-18 KR KR1020167022085A patent/KR102328636B1/ko active Active
- 2015-02-18 PL PL15752673T patent/PL3107526T3/pl unknown
- 2015-02-18 WO PCT/US2015/016267 patent/WO2015126874A1/en not_active Ceased
- 2015-02-18 AU AU2015219210A patent/AU2015219210B2/en active Active
- 2015-02-18 SI SI201531342T patent/SI3107526T1/sl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017505825A5 (enExample) | ||
| JP2008508189A5 (enExample) | ||
| ATE461214T1 (de) | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden | |
| ATE494303T1 (de) | An humane leukozytenantigen-(hla-)klasse-i- oder ii-moleküle bindende tumorassoziierte peptide und damit im zusammenhang stehender impfstoff gegen krebs | |
| JP2013517798A5 (enExample) | ||
| JP2013540292A5 (enExample) | ||
| JP2014519662A5 (enExample) | ||
| UA103751C2 (ru) | Иммуногенный пептид для иммунотерапии | |
| JP2014513356A5 (enExample) | ||
| JP2014513484A5 (enExample) | ||
| MY171100A (en) | Anti-ceacam5 antibodies and uses thereof | |
| RU2022106357A (ru) | Противораковые рнк-вакцины | |
| MA40136A1 (fr) | Nouveaux peptides et combinaisons de peptides pour une utilisation en immunothérapie contre le carcinome hépatocellulaire (chc) et autres cancers | |
| JP2013540293A5 (enExample) | ||
| MX2015013235A (es) | Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer. | |
| JP2015503918A5 (enExample) | ||
| MX2009012950A (es) | ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS. | |
| JP2008523153A5 (enExample) | ||
| EA201400237A1 (ru) | Фолатные конъюгаты альбуминсвязывающих частиц | |
| JP2012504317A5 (enExample) | ||
| JP2014520155A5 (enExample) | ||
| JP2021505241A5 (enExample) | ||
| JP2016506003A5 (enExample) | ||
| DE602006011859D1 (de) | T-cd4+-epitope der latenzantigene typ i und ii des epstein-barr-virus, die bei der mehrzahl von individuen in der kaukasischen bevölkerung erkannt werden können, und anwendungen davon | |
| TN2012000431A1 (en) | Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant |